Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Shareholder vote
confidence 98%
filed 2026-06-29
Item 5.07
This is a clear disclosure of shareholder vote results from the 2026 Annual General Meeting held on June 29, 2026. The filing reports the outcomes of six ordinary resolutions, including adoption of annual accounts, approval of directors' remuneration, auditor appointment (Ernst & Young LLP), and re-election of three directors (M Bonney, E Leiderman, and RW Azelby), with vote tallies for each resolution. This is a quintessential Item 5.07 disclosure and is material to investors as it reflects shareholder governance decisions and approval of key corporate matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 99%
filed 2026-06-29
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of UiPath's annual meeting of stockholders held on June 25, 2026. The filing presents voting results for three proposals: election of seven directors, a non-binding say-on-pay vote on named executive officer compensation, and ratification of KPMG LLP as independent auditor. All three proposals were approved by stockholders with strong majorities, and the disclosure includes detailed vote tallies (FOR, AGAINST, WITHHELD, ABSTAIN, and BROKER NON-VOTE) for each proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 92%
filed 2026-06-29
Item 5.07
Stockholders of Rhinebeck Bancorp and depositors of Rhinebeck Bank approved the Amended and Restated Plan of Conversion and Reorganization at special meetings held on June 29, 2026, converting Rhinebeck Bancorp, MHC from a mutual holding company to a fully public stock holding company structure, with 10,108,446 votes in favor and 7,369 against.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-06-29
Rocket Lab Corporation entered into a definitive Agreement and Plan of Merger with Iridium Communications Inc. on June 28, 2026, under which Rocket Lab will acquire all outstanding shares of Iridium common stock for $54 per share in a cash and stock transaction, representing an enterprise value of approximately $8.0 billion. This is a material acquisition disclosed under Item 1.01 (Entry into a Material Definitive Agreement), creating a vertically-integrated space company combining launch, spacecraft manufacturing, spectrum, and satellite communications services.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-06-29
EX-99.1
NuRAN Wireless filed a Form 40-F registration statement with the SEC in connection with an application to list on Nasdaq and confidentially filed a Preliminary Short Form Base Shelf Prospectus with the BCSC for up to C$100 million in securities, signaling strategic expansion into U.S. capital markets and enhanced financing flexibility.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-06-29
EX-99.2
The SEC declared NuRAN Wireless's Form 40-F registration statement effective as of June 26, 2026, removing a critical regulatory barrier to the Company's Nasdaq listing and opening access to U.S. institutional and retail investors.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-06-29
Item 8.01
High Roller Technologies announced that its subsidiary ROLR US LLC has been awarded a guaranteed introducing broker license from the National Futures Association, enabling entry into the U.S. prediction markets space through a partnership with Crypto.com FCM. This is a material regulatory milestone and strategic business development—the company has achieved a key regulatory approval necessary to launch its ROLR prediction markets platform. While this is operational and strategic in nature rather than a specific financial event (debt, equity, M&A, impairment, etc.), it represents a significant milestone that would affect a reasonable investor's assessment of the company's ability to execute its business plan and enter a new market segment.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-06-29
Item 8.01
Angel Oak Mortgage REIT extended a loan financing facility with Multinational Bank 1 through September 25, 2026, and negotiated a reduction in the interest rate pricing spread from 1.65%-2.10% to 1.30%-2.10%. This is a material financial event involving modification of an existing direct financial obligation (the credit facility), but it does not fit the specific categories of debt_issuance (no new debt created), covenant_breach (no breach disclosed), or debt_issuance. The extension and rate improvement are favorable developments for a mortgage REIT's financing costs and liquidity, making this a material financial event best classified as financial_other.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-29
Item 2.02
Beneficient issued a press release on June 29, 2026 announcing financial results for the fourth quarter and fiscal year ended March 31, 2026, disclosing consolidated revenues, operating income/loss, segment performance, and capital metrics.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-29
Item 2.02
Concentrix issued a press release on June 29, 2026 reporting financial results for the second quarter ended May 31, 2026, disclosing revenue of $2,462.5 million, operating income, net income, EPS, and adjusted EBITDA alongside forward guidance for Q3 and full-year 2026. This is a standard quarterly earnings release filed under Item 2.02 with the press release furnished as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-06-29
Item 1.01
MediaAlpha entered into an Assignment, Assumption and Termination Agreement on June 25, 2026, to purchase Insignia's interest in a Tax Receivables Agreement for $31.0 million in cash, reducing the Company's estimated total TRA liability from $123.4 million to approximately $55.0 million. This is a material financial transaction that reduces a significant contingent liability, but it does not fit neatly into the specific financial event categories (debt issuance, dividend distribution, material impairment, or M&A activity). The transaction is clearly financial in nature and material to investors, warranting classification as financial_other rather than a more specific category.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-29
Item 5.07
This is a clear disclosure of shareholder vote results from Tarsus Pharmaceuticals' Annual Meeting of Stockholders held on June 25, 2026. The filing reports voting outcomes on three proposals: election of four Class III directors, advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. All three proposals passed with substantial majorities. This is a routine but material governance disclosure required under Item 5.07 of Form 8-K.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-06-29
Item 8.01
The filing discloses two distinct operational and financial events: (1) early termination of a London office lease with a £0.5 million termination fee but expected savings of approximately £4.3 million over the original term, and (2) repayment of $7.5 million in debt using released letter-of-credit collateral, reducing outstanding indebtedness to $25.0 million. While the debt repayment could be classified as a financial event, the primary focus of the Item 8.01 disclosure is the lease termination as part of ongoing cost-reduction efforts, which is an operational restructuring decision. The combined impact on cash flow and operating expenses makes this material to investors assessing the company's financial trajectory.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-06-29
EX-99.1
This exhibit is a press release announcing audited financial results for Helus Pharma's fiscal year ended March 31, 2026, including net loss of $148.0 million, cash position of $157.3 million, and operating cash flows of $133.3 million. The document explicitly states "Helus Pharma Reports Recent Business Highlights and Fiscal Year 2026 Financial Results" and discloses quarterly and annual financial metrics alongside clinical pipeline updates. This is a discrete earnings announcement, not a periodic financial report itself, and is material to investors assessing the company's financial position and burn rate.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-06-29
EX-99.1
The press release announces the appointment of Ronen Assia as an independent director to Riskified's Board of Directors, effective June 25, 2026. This is a clear executive/governance appointment of a named individual to a board position. The disclosure identifies his background (Managing Partner at Team8, co-founder of eToro), qualifications, and expected contributions to the company's strategy, making it material to investors' assessment of board composition and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-29
Item 5.02
The filing discloses the appointment of Nicholas M. Maestas as Chief Financial Officer (principal financial officer and principal accounting officer) effective June 29, 2026, succeeding Svai Sanford. While the section also includes compensatory details (base salary of $500,000, 75% bonus target, and a 2,000,000-share option grant), the principal disclosed action is the appointment of a named executive to a principal officer role, making exec_appointment the most salient classification. The appointment of a CFO is material to investors as it affects the registrant's financial leadership and governance.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-06-29
Item 1.01
Barings Private Credit Corp entered into a First Amendment to its Senior Secured Revolving Credit Agreement, increasing the total facility amount from $465.0 million to $540.0 million and expanding the accordion provision to permit increases up to $750.0 million, materially expanding the Company's borrowing capacity and direct financial obligations.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-06-29
Item 6.02
This Item 6.02 discloses a change in servicer: Greystone Servicing Company LLC was removed as special servicer and CWCapital Asset Management LLC (CWCAM) was appointed as successor special servicer effective June 29, 2026, pursuant to the Pooling and Servicing Agreement. While the filing includes extensive background on CWCAM's qualifications and litigation history, the core event is a servicer transition—a governance/administrative change in the trust structure. This is material to certificateholders as it affects who manages the underlying mortgage loans and REO properties.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-29
Item 8.01
This Item 8.01 disclosure reports the Company's Net Asset Value (NAV) per share as of May 31, 2026, and provides a status update on its ongoing public and private offerings. While NAV reporting is routine for closed-end funds and investment companies, the disclosure includes material information about the Company's aggregate net asset value ($732.7 million), investment portfolio fair value ($1.06 billion), and the progress of its $2.0 billion continuous offering ($666.1 million raised to date). The event does not fit neatly into a specific category—it is neither a financial result (earnings_release), a capital transaction (debt_issuance, dilutive_issuance), nor a governance or operational event. The domain is clearly financial/informational, but the specific type is administrative NAV reporting combined with offering status, making other_material the most appropriate classification.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-06-29
Item 7.01
TPG Twin Brook Capital Income Fund declared distributions to shareholders across three share classes (Class I, S, and D) at $0.20 per share gross, with specified record and payment dates.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-06-29
Item 2.03
Indirect subsidiaries of KKR Infrastructure Conglomerate LLC entered into lender joinder agreements on June 24, 2026, increasing available credit under an existing revolving credit facility by $250 million to an aggregate of $1,550 million.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-06-29
Item 8.01
The company declared distributions across six share classes (Class I, S, U, R, D, and F) with per-share amounts ranging from $0.2648 to $0.3300, payable to shareholders of record on June 30, 2026, with payment on or about July 27, 2026.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 75%
filed 2026-06-29
Item 8.01
The 8-K discloses notice of Paramount's 2026 annual meeting of stockholders scheduled for July 21, 2026, where stockholders will vote on director elections and auditor ratification. While the filing indicates that Harbor Lights (holding 100% of Class A voting stock) has already indicated intent to approve both proposals by written consent prior to the meeting, the disclosure is fundamentally about pending stockholder voting matters and the mechanism for their approval. This is most closely aligned with shareholder_vote_results, as the filing announces the meeting and expected voting outcomes, though technically the results are pre-determined by written consent rather than a traditional vote at the meeting.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-29
Item 2.01
Blue Owl Digital Infrastructure Trust's subsidiary completed the acquisition of 100% of membership interests in GCDC Purchaser Phase 1 LLC on June 23, 2026, acquiring a 72-megawatt data center facility in Gainesville, Virginia for approximately $860.6 million, funded through cash and a $559.0 million CMBS loan.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-06-29
Item 1.01
BillionToOne entered into a material 12-year lease for approximately 62,659 square feet of laboratory and office space with aggregate base rent of $46.7 million, representing a 16% expansion of total facility space and more than tripling oncology-dedicated laboratory capacity.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-29
Item 5.02
The filing discloses the appointment of four Northfield Bancorp directors (John P. Connors, Jr., Timothy C. Harrison, Steven M. Klein, and Paul V. Stahlin) to Columbia Financial's board of directors, effective upon completion of the pending merger. This is a material executive appointment event tied to the merger transaction, with biographical details provided for each appointee and explicit reference to board size expansion from nine to thirteen directors.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-26
Item 2.02
This is a clear earnings release disclosing Apogee Enterprises' first-quarter fiscal 2027 financial results, including net sales of $342.7 million, diluted EPS of $0.54, and adjusted diluted EPS of $0.57. The press release is attached as Exhibit 99.1 and filed under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings announcements. The disclosure includes detailed segment results, financial condition metrics, and forward guidance, all typical of a quarterly earnings release.
View raw filing on EDGAR →
8-K
Exec departure
confidence 92%
filed 2026-06-26
Item 5.02
Lucille Sgaglione is resigning from her position as Executive Vice President of W. R. Berkley Corporation, effective June 30, 2026. Although she will continue in a part-time Senior Advisor role, the principal disclosed action is her departure from an executive officer position. The filing centers on the resignation and transition of her role, making this an exec_departure event material to investors assessing leadership stability.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-26
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from Oxford Industries' 2026 Annual Meeting of Shareholders held on June 23, 2026. The filing reports voting outcomes on four proposals: election of three Class I directors (Dennis M. Love, Clyde C. Tuggle, and Carol B. Yancey), approval of the Long-Term Stock Incentive Plan with 750,000 additional shares, selection of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. All proposals passed with substantial majorities, making this a material governance disclosure that affects investor understanding of board composition and corporate governance.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-06-26
Item 8.01
Stryker announced a material reorganization of its business structure in Q1 2026, combining the orthopaedic instruments portfolio with Mako and enabling technologies into a new "Ortho Tech" business. This restructuring changes the company's segment reporting from three segments to two (MedSurg and Neurotechnology, and Orthopaedics), affecting how financial results are presented and analyzed. While the filing emphasizes this is a "recast" rather than a restatement, the organizational restructuring and resulting segment reporting changes are material operational events that would affect investor understanding of the company's business structure and performance metrics.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 95%
filed 2026-06-26
Item 8.01
This disclosure centers on a material litigation matter involving ARK Restaurants' dispute with Bryant Park Corporation over three restaurant leases. The Company filed suit on March 28, 2025, alleging defective bidding processes and violation of right-of-first-lease provisions, and subsequently added age discrimination claims. A June 18, 2026 summary judgment decision granted the Company damages for breach of contract but denied specific performance and allowed the Landlord's ejectment claim to proceed. The Company explicitly states the dispute "has had, and is expected to continue to have, a material adverse impact on our business, financial condition, and results of operations," making this a core material litigation disclosure under Item 8.01.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 82%
filed 2026-06-26
Item 2.03
The Company entered into a Second Amendment to its Credit Agreement effective June 25, 2026, which revises financial covenants (total leverage ratio and senior secured leverage ratio thresholds) and creates or modifies direct financial obligations. The amendment reflects changes in the Company's risk profile in connection with its execution of an Asset Purchase Agreement.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-26
Item 5.02
The filing discloses both the departure of Paul Krause as Chief Legal, Compliance and Corporate Affairs Officer and the appointment of Gayle Littleton to the same role, effective June 29, 2026. While both events occur, the principal action emphasized is the appointment of Littleton to fill the critical legal and compliance leadership position. The departure is framed as supporting an orderly transition, making the appointment the salient event. This is material as it involves a named executive officer in a key governance role.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-26
Item 2.01
Stratus completed the disposition of the retail component of Jones Crossing to Brixmor Operating Partnership LP for $46.5 million in gross cash proceeds, generating approximately $21.7 million in net proceeds after costs and loan payoff. This material asset sale represents the fourth recent stabilized retail project sale and is a key step in executing the company's stockholder-approved Plan of Liquidation announced on June 1, 2026.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-06-26
Item 5.02
Gregory M. Larson, Vice President – Accounting & Controller, resigned on June 23, 2026. While the filing also discloses that Marcel Teunissen assumed interim principal accounting officer duties, the principal disclosed action is Larson's departure. The resignation of a controller—a key accounting officer responsible for financial reporting—is material to investors assessing the registrant's financial controls and reporting integrity.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-06-26
IRSA has signed a barter agreement for a 6,947 sqm lot with 17,500 sqm total saleable area as part of the "Ramblas del Plata" project, valued at USD 14.175 million. This is a material real-estate transaction involving acquisition of development land and commitment to infrastructure work, but it is neither a discrete M&A event (no acquisition of a company or business unit) nor a standard financial obligation. It is a significant operational/strategic real-estate development milestone that would affect investor assessment of the company's project pipeline and capital deployment.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-26
Item 1.01
ADP entered into two new revolving credit facilities totaling $9.2 billion ($5.7 billion 364-Day Facility and $3.5 billion Five-Year Facility) on June 26, 2026, replacing prior facilities of similar size. The syndicated facilities with major lenders (JPMorgan, Bank of America, BNP Paribas, Wells Fargo, Deutsche Bank) constitute material new direct financial obligations.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-06-26
EX-99
This disclosure announces the conclusion of a legal review initiated following Mr. Atanu Chakraborty's resignation as an executive officer. The external law firms (Wilson Sonsini and Wadia Ghandy) conducted a three-month investigation into concerns raised in his resignation letter and found his allegations unsubstantiated. While the resignation itself occurred earlier (March 24, 2026), this announcement of the legal review's outcome is a governance event addressing the integrity of board processes and management conduct — material to investors assessing the bank's governance and leadership credibility.
View raw filing on EDGAR →
6-K
M&A activity
confidence 85%
filed 2026-06-26
EX-99.1
Zentek has formed Strategic Graphite Partners LLC, a joint venture with ALO Graphite Partners LLC, in which Zentek USA Inc. holds 90% ownership and ALO Partners holds 10%. This constitutes entry into a material joint venture arrangement designed to establish a U.S. footprint for Zentek's Albany ultra-high-purity graphite in energy, defense, and national-security markets. The JV structure, governance, and strategic purpose to access federal and allied government funding programs represent a material change in the company's capital structure and market positioning.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 98%
filed 2026-06-26
EX-99.1
This is a voting results report filed pursuant to National Instrument 51-102 disclosing the outcomes of Trekor Metals Limited's annual general meeting held on June 24, 2026. The exhibit presents detailed voting tallies for six items: auditor appointment (99.43% in favor), director count (98.70% in favor), election of nine directors (ranging from 73.8% to 99.2% in favor), name change approval (95.57% in favor), plan amendments (70.16% in favor), and say-on-pay advisory vote (96.20% in favor). This is a classic shareholder_vote_results disclosure documenting the formal outcomes of shareholder votes at an annual meeting.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-26
Item 1.01
Energy Fuels Inc. entered into a definitive merger agreement on June 23, 2026, to acquire the Ara VAC entities for aggregate consideration of $718 million in cash, 65.853 million common shares, and potentially preferred shares up to $135 million, subject to customary closing conditions including HSR Act approval.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 90%
filed 2026-06-26
Item 2.03
Energy Fuels Inc. entered into a Senior Secured Term Loan Commitment Letter as part of the financing for the Ara VAC acquisition, creating a material direct financial obligation.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-26
Item 5.07
Energy Fuels Inc. held its 2026 annual meeting of shareholders on June 24, 2026, with voting results reported on four proposals: election of seven directors, appointment of KPMG LLP as auditors, a Say-on-Pay advisory vote, and a Say-When-On-Pay advisory vote.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-06-26
Item 8.01
Energy Fuels Inc. received a conditional $725 million financing commitment from the U.S. Department of War's Office of Strategic Capital for a 20-year loan to support expansion of critical minerals processing and rare earth metals facilities.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-26
Item 8.01
The filing discloses an increase in the amount available for sale under an At The Market (ATM) Offering Agreement by an additional $15,000,000 of common shares. The Company has already sold 1,804,444 shares for approximately $12.66 million since May 2024, and this new authorization substantially expands the dilutive issuance capacity. ATM offerings are classic dilutive equity issuances that signal capital-raising activity and shareholder dilution, particularly material for a small-cap company like Ascent Solar with only 9.8 million shares outstanding as of the filing date.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-26
Item 5.02
The filing's primary disclosure is the appointment of Joseph R. Hinrichs as a director and expected future Chair of the Board, effective June 25, 2026. While the Item 5.02 section also covers compensatory arrangements (director compensation, CEO salary/equity increases, and adoption of new compensation plans), the salient event centers on the executive appointment. The appointment of an independent director with audit committee expertise to lead the board of a newly spun-off company is material to investors assessing governance and leadership continuity post-separation.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-26
Item 5.07
This is a classic Item 5.07 disclosure reporting the final voting results from SmartKem's Annual Meeting of Stockholders held on June 23, 2026. The filing presents detailed vote tallies for all eleven proposals submitted to shareholders, including director elections, executive compensation advisory votes, auditor ratification, and multiple charter amendments. The disclosure of shareholder vote results is material as it reflects stockholder approval of significant corporate actions including authorization increases and governance changes.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-06-26
EX-99.1
The exhibit announces voting results from H World's 2026 Annual General Meeting held on June 26, 2026. It discloses passage of four ordinary resolutions: ratification of Deloitte as auditor, re-election of Justin Martin Leverenz as director, re-election of Yi Zhang as independent director and audit committee chairwoman, and authorization for implementation actions. This is a classic shareholder_vote_results disclosure reporting outcomes of an annual meeting vote.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 95%
filed 2026-06-26
EX-99.1
The exhibit announces a US$20 million share repurchase program approved by the Board, effective July 1, 2026. Share repurchases are a form of capital return to shareholders and fall within the dividend_distribution category, which explicitly includes "share-repurchase programs." The program is material as it represents a significant commitment of the company's cash resources (approximately 6.6% of the US$303.6 million cash balance as of March 31, 2026) and signals management confidence in the company's valuation and operational performance.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-06-26
Item 7.01
The disclosure announces FDA acceptance of a Biologics License Application (BLA) resubmission for RP1 in advanced melanoma with an expedited review timeline (decision expected by August 2, 2026) and an advisory committee meeting planned. This is a material regulatory milestone for a clinical-stage biotech company's lead product candidate, but it does not fit the specific event types of earnings release, M&A activity, impairment, or other defined categories. It is clearly operational/strategic in nature—a significant product development and regulatory advancement event.
View raw filing on EDGAR →